3849011000036107: Angiomax (trade product)
Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Angiomax 250 mg powder for injection, 10 vials |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 250 mg powder for injection, 10 vials |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 250 mg powder for injection, 250 mg vial |
Is a |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 250 mg powder for injection, 1 vial |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 250 mg powder for injection, 1 vial |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 100 mg powder for injection, 1 vial |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 100 mg powder for injection, 10 vials |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax (bivalirudin 100 mg) powder for injection, 10 x 100 mg vials (trade product pack) |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 100 mg powder for injection, 100 mg vial |
Is a |
True |
Angiomax |
Inferred relationship |
Some |
|
Angiomax 100 mg powder for injection, 1 vial |
has TP |
True |
Angiomax |
Inferred relationship |
Some |
|
Reference Sets
Trade product reference set
Back to Start